Today: 21 May 2026
Browse Category

NYSE:NOC 20 December 2025 - 8 January 2026

Northrop Grumman stock rebounds as Trump buyback ban meets $1.5 trillion defense budget pitch

Northrop Grumman stock rebounds as Trump buyback ban meets $1.5 trillion defense budget pitch

Northrop Grumman shares rose 3.8% to $598.96 midday Thursday after President Trump ordered defense contractors to halt dividends and buybacks until weapons output improves. The stock rebounded as Trump also called for a $1.5 trillion military budget in 2027 and Northrop announced new Navy and Marine Corps contracts for rocket motors and uncrewed aircraft.
8 January 2026
··
Dow Jones Today: Dow steadies near record highs as jobs report looms and Trump defense talk jolts stocks

Dow Jones Today: Dow steadies near record highs as jobs report looms and Trump defense talk jolts stocks

The Dow rose 129 points, or 0.3%, to 49,124.87 by mid-morning Thursday, recovering after a sharp drop Wednesday. Weekly jobless claims increased to 208,000, while defense stocks climbed after Donald Trump called for a $1.5 trillion military budget. Investors await Friday’s U.S. jobs report for clues on Federal Reserve rate moves.
8 January 2026
····
US economic calendar today: What to watch as U.S. stock futures slip before Friday’s jobs report

US economic calendar today: What to watch as U.S. stock futures slip before Friday’s jobs report

U.S. stock futures fell early Thursday, with Dow futures down 146 points, as traders awaited Friday’s nonfarm payrolls report. Defense stocks surged after Donald Trump proposed a $1.5 trillion military budget for 2027. Lockheed Martin jumped 7.2%, Northrop Grumman 7.5%, and RTX 4.9%. Key economic data, including jobless claims and trade figures, are due at 8:30 a.m. ET.
8 January 2026
····
Space and Defense Stocks Jump as Trump Pitches $1.5 Trillion Military Budget, Despite Buyback Crackdown

Space and Defense Stocks Jump as Trump Pitches $1.5 Trillion Military Budget, Despite Buyback Crackdown

Lockheed Martin rose 7.2% and Northrop Grumman 7.5% in early premarket Thursday after President Trump called for a $1.5 trillion military budget for 2027. The gains followed steep losses Wednesday after Trump ordered a crackdown on dividends and buybacks at underperforming contractors. RTX climbed 4.9% and Kratos Defense 7.1%. Investors await Friday’s U.S. payrolls report and Pentagon guidance on the new rules.
8 January 2026
····
Northrop Grumman stock whipsaws: NOC jumps premarket after Trump’s $1.5T budget pushNew York,

Northrop Grumman stock whipsaws: NOC jumps premarket after Trump’s $1.5T budget pushNew York,

Northrop Grumman shares rose 7.4% to $619.50 in premarket trading Thursday, rebounding after a 5.5% drop following President Trump’s executive order halting dividends and buybacks at defense contractors until production improves. The order also threatens executive pay caps and directs the Pentagon to review underperformers. Investors await enforcement details and Northrop’s Jan. 27 results.
8 January 2026
··
Dow Jones falls from intraday record as Trump policy moves hit financials; jobs report next

Dow Jones falls from intraday record as Trump policy moves hit financials; jobs report next

The Dow Jones fell 0.94% to 48,996.08 after Trump proposed banning Wall Street from buying single-family homes and restricting defense contractor payouts, sending financial and defense stocks lower. JPMorgan dropped 2.3% after a downgrade. Nvidia and Alphabet gains lifted the Nasdaq 0.16%. Investors await Friday’s U.S. payrolls report for rate signals.
7 January 2026
······
Why Lockheed Martin stock is sliding: Trump payout threat collides with PAC-3 missile ramp and a Goldman sell

Why Lockheed Martin stock is sliding: Trump payout threat collides with PAC-3 missile ramp and a Goldman sell

Lockheed Martin shares dropped 4.5% after President Trump threatened to block dividends and buybacks for defense contractors until weapons production speeds up. The company had just reached a seven-year framework with the U.S. Department of War to raise PAC-3 MSE interceptor output to 2,000 units annually. Goldman Sachs reiterated a Sell rating, citing higher contractor risk under new deal structures.
7 January 2026
······
Rocket Lab Corporation stock rises after Cantor reiteration as investors track Neutron and Space Force work

Rocket Lab Corporation stock rises after Cantor reiteration as investors track Neutron and Space Force work

Rocket Lab shares closed at $78.15, up 2.8%, before slipping 0.7% after hours. The stock remains near a 52-week high after a December $816 million U.S. defense satellite contract win. Cantor Fitzgerald reiterated an Overweight rating and $72 price target. Investors await updates at Needham’s Growth Conference on Jan. 13–14.
6 January 2026
·····
Lockheed, RTX in focus as U.S. attack on Venezuela puts defense stocks on watch for Monday

Lockheed, RTX in focus as U.S. attack on Venezuela puts defense stocks on watch for Monday

Nicolas Maduro is in U.S. custody in New York after a U.S. military raid in Venezuela, and will appear in Manhattan court Monday. Aerospace and defense stocks surged Friday, with Lockheed Martin up 2.8% and sector ETFs gaining over 3%. President Trump confirmed the operation, which involved more than 150 aircraft. Markets are closed until Monday, leaving investors waiting to gauge reaction.
4 January 2026
·····
RTX stock jumps to start 2026 as defense names catch a bid; jobs report, earnings loom

RTX stock jumps to start 2026 as defense names catch a bid; jobs report, earnings loom

RTX Corp shares closed up 2.1% at $187.25 on Friday, with about 3.3 million shares traded. The stock tracked gains across U.S. defense peers as investors returned after the holidays. Traders are watching upcoming U.S. jobs and inflation data for rate clues. RTX’s next earnings report is expected in late January.
4 January 2026
······
Defense and space stocks jump to start 2026 as Boeing, Rocket Lab lead gains

Defense and space stocks jump to start 2026 as Boeing, Rocket Lab lead gains

U.S. aerospace and defense stocks surged Friday, with Boeing up 4.91% after a $2.7 billion Pentagon contract for Apache helicopter support. Lockheed Martin rose 2.77%, Rocket Lab gained 8.93%, and Intuitive Machines climbed 10.17%. The sector tracked geopolitical headlines and new White House policy on commercial space. The Dow and S&P 500 ended higher; Nasdaq slipped.
3 January 2026
·········
Boeing stock today slips as year-end trading thins, despite $8.6B Pentagon F-15 deal

Boeing stock today slips as year-end trading thins, despite $8.6B Pentagon F-15 deal

Boeing shares slipped 0.4% to $217.61 in midday New York trading Wednesday after the Pentagon awarded the company an $8.6 billion contract for F-15 jets for Israel. U.S. stocks edged lower in thin, year-end volumes, with defense peers also down. The F-15 contract runs through 2035 and includes 25 new jets, with an option for 25 more.
31 December 2025
······
Rocket Lab stock rises as traders revisit Space Force satellite deal after Friday slump

Rocket Lab stock rises as traders revisit Space Force satellite deal after Friday slump

Rocket Lab shares rose 1.6% to $71.78 by late morning Monday, recovering some ground after an 8.5% drop in the previous session. The company disclosed an $816 million contract to build 18 missile-warning satellites for the U.S. Space Force, with deliveries expected in 2029. The Nasdaq fell 0.7% and the S&P 500 dropped 0.5%.
29 December 2025
······
Industrials Stocks Outlook: Defense, Transport, and Capex Themes Head Into the Final Week of 2025

Industrials Stocks Outlook: Defense, Transport, and Capex Themes Head Into the Final Week of 2025

U.S. industrials stocks held gains in thin post-holiday trading, with the sector seen as a year-end leader despite light volume. Defense shares drew attention after China imposed new sanctions on U.S. firms tied to Taiwan arms sales. The broader market closed slightly lower Friday, tracking the seasonal “Santa Claus rally” period. Investors are watching defense spending, transport demand, and business investment as 2026 approaches.
27 December 2025
···········
Space and Defense Stocks: Rocket Lab, Lockheed, Northrop, RTX in Focus as China Sanctions and Space Force Awards Shape 2026

Space and Defense Stocks: Rocket Lab, Lockheed, Northrop, RTX in Focus as China Sanctions and Space Force Awards Shape 2026

China announced sanctions late Friday against 20 U.S. defense firms, including Boeing’s St. Louis branch, Northrop Grumman Systems, and L3Harris Maritime Services, over arms sales to Taiwan. The move freezes assets in China and blocks business with Chinese entities. U.S. markets closed Friday nearly flat in light post-holiday trading. Investors are watching space and defense stocks ahead of Monday’s open.
27 December 2025
·······
Military Tech Stocks Week Ahead (Dec. 22–26, 2025): Space Force Satellite Awards, Drone Dominance, and Analyst Calls in Focus

Military Tech Stocks Week Ahead (Dec. 22–26, 2025): Space Force Satellite Awards, Drone Dominance, and Analyst Calls in Focus

The U.S. Space Force’s Space Development Agency awarded $3.5 billion in contracts to Lockheed Martin, L3Harris, Northrop Grumman, and Rocket Lab to build 72 Tracking Layer satellites for missile defense. Each company will deliver 18 satellites under fixed-price agreements. The contracts mark a shift toward recurring tech upgrades in defense spending. Markets may see outsized moves due to thin holiday trading.
21 December 2025
······
Rocket Lab Stock (RKLB) Surges After $805M–$816M SDA Satellite Deal: Latest News, Analyst Forecasts, and 2026 Outlook

Rocket Lab Stock (RKLB) Surges After $805M–$816M SDA Satellite Deal: Latest News, Analyst Forecasts, and 2026 Outlook

Rocket Lab shares jumped 17.7% to a record $70.52 on December 19 after winning a U.S. Space Development Agency contract to build 18 missile-warning satellites for Tranche 3 of the Tracking Layer program. The SDA values Rocket Lab’s award at $805 million, while the company cites $816 million including options. The contract is part of a $3.5 billion effort split among four primes, with launches targeted for 2029.
20 December 2025
·····
1 2 3 4

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop